Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 7 Head & Neck 4 Gastrointestinal 4 Thoracic 3 Sarcoma 3 Genitourinary 3 Tumor-Agnostic 1 Plasma cell 1 Other solid neoplasm 1 Lymphoid 1 Breast 1

Conditions

Mesothelioma, Malignant 1

Interventions

pembrolizumab 30 Injections 26 Pemetrexed 15 Interviews as Topic 15 tislelizumab 13 Specimen Handling 13 Carboplatin 13 Cisplatin 12 Nivolumab 11 atezolizumab 10 Practice Guidelines as Topic 9 Educational Status 9 Cyclophosphamide 9 Bevacizumab 9 Standard of Care 8 Oxaliplatin 8 Fluorouracil 8 fludarabine 7 Methods 7 Early Intervention, Educational 7 Docetaxel 7 Cetuximab 7 Capecitabine 7 toripalimab 6 sotorasib 6 Platinum 6 Paclitaxel 6 Leucovorin 6 Ipilimumab 6 Gemcitabine 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Proton Therapy × Other solid neoplasm × 90 days × Clear all

NCT05655078 2026-03-30

HIT-Meso

University College, London

Phase NA Recruiting

Other solid neoplasmThoracic

Mesothelioma, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon ⚡